Affimed N.V. (NASDAQ:AFMD) traded at $4.51 at last check on Monday, Jun 29, making a downturn move of -2.59% on its previous day’s price.

Looking at the stock we see that its previous close was $4.63 and the beta (5Y monthly) reads 2.85 with the day’s price range being $4.4500 – 4.7600. In terms of its 52-week price range, AFMD has a high of $4.77 and a low of $1.42. The company’s stock has gained about 37.08% over that past 30 days.

Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $4.76 Million, with a low of $3.1 Million and a high of $6.93 Million. The median projection represents growth adding up to 7.8% compared to sales earnings for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecasts for 2020 are expected to hit $20.09 Million, or -6.1% down from figures reported last year.

There have been 4 upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the AFMD stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 50% Buy.

Let’s briefly compare Affimed (AFMD) stock to its peers. We find that today’s price change of -2.59% and +57.14% over the past 12 months for AFMD competes that of Amgen Inc (AMGN), which has seen its stock price fall -0.55% in the latest trading session and is +25.66% over the last one year. Another of its peers Gilead Sciences Inc (GILD) has dropped -0.01% today, and is +10.36% up over the past year, while Vertex Pharmaceutic (VRTX) is also down -2.59% yet its price remains in the green at 57.14% over the same period. Amgen has a P/E ratio of 18.14 compared to Affimed’s 0 and Gilead’s 19.17. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 2.32% and 1.47%, respectively, in early deals.

Coming back to Affimed N.V. (NASDAQ:AFMD), we note that the average 3-month trading volume was 1.51 Million, while that of the preceding 10-day period stands at 2.85 Million. Current shares outstanding are 76.25 Million.

According to data from Thomson Reuters, insiders hold 7.5% of the company’s shares while institutions hold 59.17%. The data shows that short shares as of June 14, 2020, stood at 1.88 Million at a short ratio of 0.96. This represents a 2.47% Short interest in Shares outstanding on June 14, 2020. Shares short dropped in June from the previous month at 2.32 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock +64.6% up in year-to-date price movement.